Insurers Drop Gender-Affirming Coverage on BeWell, San Juan County Residents Affected

Two major carriers offering plans on New Mexico’s BeWell marketplace removed coverage for certain gender-affirming pharmaceutical and surgical care, creating immediate disruptions for people across the state, including residents of San Juan County.

UnitedHealthcare and Blue Cross Blue Shield of New Mexico adopted plan language excluding coverage for interventions the insurers described as intended to alter sex traits. The changes surfaced just after the marketplace plan-selection window closed, leaving some policyholders without coverage for ongoing gender-affirming treatments they had relied on when enrolling.

The policy shift affected people who depend on marketplace plans for hormones and surgeries. A University of New Mexico doctoral student reported an immediate loss of coverage for testosterone and for a planned hysterectomy. Advocacy groups in New Mexico are urging affected residents to review alternative plans on the marketplace that continue to cover gender-affirming care and to act quickly to avoid interruptions in treatment.

Legal and regulatory context complicates the situation. New Mexico’s 2023 Reproductive and Gender‑Affirming Health Care Freedom Act protects the right of individuals to seek gender-affirming care but does not require private insurers to cover those services. State lawmakers, including Representative Linda Serrato, and the Office of the Superintendent of Insurance are weighing possible responses, which could include legislative changes or regulatory remedies aimed at restoring coverage or preventing similar exclusions in future plan contracts.

The change appears to apply to marketplace plans sold through BeWell, not to New Mexico Medicaid, which remains governed by different rules. For San Juan County residents who rely on employer plans or Medicaid, impacts may differ. For people insured through the marketplace, the exclusion could mean paying out of pocket for prescriptions or delaying scheduled procedures, unless they can switch to a different plan that retains coverage or secure other funding.

Local clinics and community advocates warn that sudden gaps in hormone therapy and surgical care can have real health and mental health consequences. The timing after the enrollment window reduces options for immediate plan changes and raises questions about how insurers communicated the exclusions during enrollment. Lawmakers and regulators may pursue remedies that could include requiring clearer disclosures, revisiting plan approvals, or seeking to limit such exclusions.

For now, affected residents in San Juan County should check their plan documents, speak with health care providers about continuity of care, and contact the Office of the Superintendent of Insurance and their state representatives to report coverage disruptions. As policymakers consider next steps, the practical consequences for patients, missed doses, delayed procedures, and sudden financial burdens, will determine the urgency and shape of any regulatory or legislative response.